---
title: "Celltrion Launches Anti-Inflammatory Drug Biosimilar in US; Shares Rise 3%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279365100.md"
description: "Celltrion Launches Anti-Inflammatory Drug Biosimilar in US; Shares Rise 3%"
datetime: "2026-03-17T04:10:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279365100.md)
  - [en](https://longbridge.com/en/news/279365100.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279365100.md)
---

# Celltrion Launches Anti-Inflammatory Drug Biosimilar in US; Shares Rise 3%

Celltrion Launches Anti-Inflammatory Drug Biosimilar in US; Shares Rise 3%

### Related Stocks

- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [CYCN.US](https://longbridge.com/en/quote/CYCN.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [CTMX.US](https://longbridge.com/en/quote/CTMX.US.md)
- [LCTX.US](https://longbridge.com/en/quote/LCTX.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)

## Related News & Research

- [Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T Platform](https://longbridge.com/en/news/282587297.md)
- [Pancreatic cancer pill shown to nearly double overall survival time, drug company says](https://longbridge.com/en/news/282687539.md)
- [Allogene's blood cancer therapy delays cancer relapse in mid-stage study](https://longbridge.com/en/news/282537381.md)
- [BUZZ-Allogene tumbles on $175 mln stock offering after cancer therapy data](https://longbridge.com/en/news/282722450.md)
- [FDA Rejection Sparks Questions On Replimune Drug Approval Path](https://longbridge.com/en/news/282577359.md)